Novo Nordisk’s CEO took a $1.5 million pay cut in 2024 as the pharma giant’s share price tanked and it missed profit and DEI targets. Read More
Novo Nordisk missed its diversity targets last year, and its CEO paid a financial price

Novo Nordisk’s CEO took a $1.5 million pay cut in 2024 as the pharma giant’s share price tanked and it missed profit and DEI targets. Read More